Key result
Routine DES postdilatation is linked to ~36% lower 12-month MACE vs standard treatment.
Why the study?
Suboptimal stent expansion occurs after DES deployment, and it is unclear whether routine postdilatation improves clinical outcomes.
Cohort (n=541)
Absolute Event Rate: 12.5% vs 19.5%
p-value: p=0.04
No takes yet. Share an insight, caveat, or question.
Routine postdilatation of DES may improve expansion and outcomes; hypothesis-generating and requires randomized confirmation.
Pasceri et al. (2013) conducted a cohort in Patients receiving drug-eluting stents (n=541). Routine postdilatation with noncompliant balloons vs. Standard treatment (postdilatation only for suboptimal results) was evaluated on MACE (including periprocedural myocardial infarction) (p=0.04). Routine postdilatation of drug-eluting stents with noncompliant balloons was associated with a lower 12-month incidence of MACE compared to standard treatment (12.5% vs 19.5%; P=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: